Issued Patents 2017
Showing 1–6 of 6 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 9822107 | Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors | Kenneth L. Arrington, Ryan D. Otte, John Michael Ellis, John W. Butcher, Alan B. Northrup +3 more | 2017-11-21 |
| 9809561 | Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease | Thomas D. Aicher, Chad A. VanHuis, William D. Thomas, John MacLean, Kenneth J. Barr +9 more | 2017-11-07 |
| 9783511 | Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease | Thomas D. Aicher, Chad A. VanHuis, John MacLean, Kenneth J. Barr, Corey E. Bienstock +6 more | 2017-10-10 |
| 9745295 | Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors | Neville J. Anthony, Alan B. Northrup, Kaleen Konrad Childers, Anthony Donofrio, Thomas Miller +14 more | 2017-08-29 |
| 9663502 | 2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease | Thomas D. Aicher, Chad A. VanHuis, John MacLean, Kenneth J. Barr, Corey E. Bienstock +9 more | 2017-05-30 |
| 9598405 | Thiazole-substituted aminopyridines as spleen tyrosine kinase inhibitors | Michael D. Altman, Kenneth L. Arrington, Kaleen Konrad Childers, Maria Emilia Di Francesco, John Michael Ellis +8 more | 2017-03-21 |